Các bài viết có thể truy cập công khai - Guido MarcucciTìm hiểu thêm
Không có ở bất kỳ nơi nào: 13
Đánh giá
Curcumin is a potent DNA hypomethylation agent
Z Liu, Z Xie, W Jones, RE Pavlovicz, S Liu, J Yu, P Li, J Lin, JR Fuchs, ...
Bioorganic & medicinal chemistry letters 19 (3), 706-709, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review
CD Baldus, K Mrózek, G Marcucci, CD Bloomfield
British journal of haematology 137 (5), 387-400, 2007
Các cơ quan ủy nhiệm: German Research Foundation
Đánh giá
Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology
DA Pollyea, JK Altman, R Assi, D Bixby, AT Fathi, JM Foran, I Gojo, ...
Journal of the National Comprehensive Cancer Network 21 (5), 503-513, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Low dose decitabine in very high risk relapsed or refractory acute myeloid leukaemia in children and young adults
CL Phillips, SM Davies, R McMasters, M Absalon, M O'Brien, J Mo, ...
British journal of haematology 161 (3), 406-410, 2013
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
MicroRNA expression in acute myeloid leukemia
G Marcucci, MD Radmacher, K Mrózek, CD Bloomfield
Current hematologic malignancy reports 4 (2), 83-88, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias
G Marcucci, K Mrózek, MD Radmacher, CD Bloomfield, CM Croce
Best practice & research Clinical haematology 22 (2), 239-248, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804
RM Stone, KA Donohue, W Stock, V Hars, CA Linker, T Shea, ...
Cancer chemotherapy and pharmacology 63, 859-864, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Antileukemic activity and cellular effects of the antimalarial agent artesunate in acute myeloid leukemia
B Kumar, A Kalvala, S Chu, S Rosen, SJ Forman, G Marcucci, CC Chen, ...
Leukemia research 59, 124-135, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Clinical experience with venetoclax and hypomethylating agents (HMA) in patients with newly diagnosed and relapsed or refractory KMT2A-Rearranged acute myeloid leukemia (AML)
BJ Ball, S Arslan, P Koller, D Ngo, M Afkhami, A Salhotra, M Al-Malki, ...
Leukemia & Lymphoma 63 (13), 3232-3236, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell …
A Salhotra, D Yang, S Mokhtari, S Hui, MM Al Malki, S Armenian, B Sigala, ...
Leukemia & Lymphoma 63 (5), 1220-1226, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
WT1-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens
A Aribi, A Salhotra, M Afkhami, A Munteanu, H Ali, I Aldoss, S Otoukesh, ...
Leukemia & Lymphoma 64 (11), 1811-1821, 2023
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
PC-12 Bone marrow microenvironment-induced miR-300 expression impairs natural killer cell proliferation and anti-tumor activity
R Trotta, G Silvestri, L Stramucci, G Marcucci, M Guimond, X Fan, M Baer, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 81, 63, 2019
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Leukemias
G Marcucci, M Wetzler, JC Byrd, K Mrózek, CD Bloomfield
Textbook of Medical Oncology, 227-247, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Có tại một số nơi: 335
Đánh giá
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
RM Stone, SJ Mandrekar, BL Sanford, K Laumann, S Geyer, ...
New England Journal of Medicine 377 (5), 454-464, 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Targeting microRNAs in cancer: rationale, strategies and challenges
R Garzon, G Marcucci, CM Croce
Nature reviews Drug discovery 9 (10), 775-789, 2010
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England journal of medicine 371 (11), 1005-1015, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia …
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, ...
Journal of clinical oncology 28 (14), 2348-2355, 2010
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling
R Su, L Dong, C Li, S Nachtergaele, M Wunderlich, Y Qing, X Deng, ...
Cell 172 (1), 90-105. e23, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health, Howard Hughes Medical Institute, Damon …
Đánh giá
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly …
R Garzon, S Liu, M Fabbri, Z Liu, CEA Heaphy, E Callegari, S Schwind, ...
Blood, The Journal of the American Society of Hematology 113 (25), 6411-6418, 2009
Các cơ quan ủy nhiệm: US National Institutes of Health
Đánh giá
METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m6A modification
H Weng, H Huang, H Wu, X Qin, BS Zhao, L Dong, H Shi, J Skibbe, ...
Cell stem cell 22 (2), 191-205. e9, 2018
Các cơ quan ủy nhiệm: US National Institutes of Health, Howard Hughes Medical Institute, National …
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ